Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Motilal Oswal Securities Ltd.
$115.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

IPCA Laboratories Ltd Enters Into Agreement With M/s. Avik Pharmaceutical Ltd


Monday, 18 Nov 2013 07:14am EST 

IPCA Laboratories Ltd announced that the Company has entered into an Agreement with M/s. Avik Pharmaceutical Ltd. (Avik) to acquire 50% of its paid-up equity share capital, partly thru purchase of equity shares from its existing shareholders and partly thru subscription to its fresh equity share capital on a preferential allotment basis, both aggregating to approx INR65.1 million (INR6.51 crores). 

Company Quote

698.0
8.0 +1.16%
6:22am EDT